Hi,
I think the point SI made in one of the CC was Mesoblast have run two heart trials . CHF and a soon to be completed LVAD trial which I thought had 150
patients and the cohort very similar to CHF.
I also think it is fair to say Perin and the Texas Heart Institute are highly regarded.
In with a shot .
Aloha.
Ann: Biotech Showcase 2022 Presentation, page-15
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.060(5.83%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.10 | $1.03 | $4.925M | 4.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7260 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 67541 | 7 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |